CIRRX | IARYX | CIRRX / IARYX | |
Total Expense Ratio | 1.25 | 1.13 | 111% |
Annual Report Gross Expense Ratio | 1.25 | 1.13 | 111% |
Fund Existence | 11 years | 17 years | - |
Gain YTD | 3.358 | 0.114 | 2,938% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 690M | 1,211% |
Annual Yield % from dividends | 2.37 | 2.17 | 109% |
Returns for 1 year | -2.89 | -6.79 | 43% |
Returns for 3 years | 32.51 | 7.63 | 426% |
Returns for 5 years | 25.80 | -0.40 | -6,378% |
Returns for 10 years | 52.52 | -24.90 | -211% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NECCX | 14.82 | N/A | N/A |
Natixis US Equity Opportunities C | |||
JFNSX | 70.53 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
VMCPX | 398.15 | N/A | N/A |
Vanguard Mid Cap Index InstitutionalPlus | |||
BGLAX | 14.96 | N/A | N/A |
Brookfield Global Listed InfrastructureA | |||
BRWRX | 27.61 | -0.02 | -0.07% |
MFS Blended Research Growth Eq R1 |